BOSTON—Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers ...
A genetic marker that predicts which aggressive triple negative breast cancers and certain ovarian cancers will respond to platinum-based chemotherapies has been identified A genetic marker that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback